{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:12:40Z","timestamp":1793725960167,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.atherosclerosis.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:08:36Z","timestamp":1569323316000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":212,"special_numbering":"C","title":["Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review"],"prefix":"10.1016","volume":"293","author":[{"given":"Giancarlo","family":"Agnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill J.F.","family":"Belch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Periklis","family":"Giovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archinte.163.8.884","article-title":"Critical issues in peripheral arterial disease detection and management: a call to action","volume":"163","author":"Belch","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacc.2015.12.049","article-title":"Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options","volume":"67","author":"Olin","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib4","first-page":"38","article-title":"One-year costs in patients with a history of or at risk for atherothrombosis in the United States Clinical Perspective","volume":"1","author":"Mahoney","year":"2008","journal-title":"Circ: Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","article-title":"National health care costs of peripheral arterial disease in the Medicare population","volume":"13","author":"Hirsch","year":"2008","journal-title":"Vasc. Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2006.03.011","article-title":"Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review","volume":"189","author":"Heald","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"Committee","year":"1996","journal-title":"The Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib9","first-page":"217","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"2007","author":"Investigators","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib13","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","article-title":"Peripheral artery disease: epidemiology and global perspectives","volume":"14","author":"Fowkes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2009.11.023","article-title":"Diabetes and coronary heart disease as risk factors for mortality in older adults","volume":"123","author":"Carnethon","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.112.141572","article-title":"A history of stroke\/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease","volume":"127","author":"Ducrocq","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib21","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diacare.28.7.1588","article-title":"Should diabetes be considered a coronary heart disease risk equivalent?","volume":"28","author":"Whiteley","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib25","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.atherosclerosis.2008.10.023","article-title":"Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"204","author":"Cacoub","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib27","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jvs.2011.09.001","volume":"54","author":"Rooke","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib29","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"Pradhan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005967","article-title":"Twenty\u2010year predictors of peripheral arterial disease compared with coronary heart disease in the Scottish Heart Health Extended Cohort (SHHEC)","volume":"6","author":"Tunstall\u2010Pedoe","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib33","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","author":"Group","year":"2007","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9149(97)00904-1","article-title":"Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)","volume":"81","author":"Pedersen","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib36","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jvir.2016.05.037","article-title":"The influence of statin therapy on restenosis in patients who underwent nitinol stent implantation for de novo femoropopliteal artery disease: two-year follow-up at a single center","volume":"27","author":"Kim","year":"2016","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","article-title":"The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease","volume":"45","author":"Feringa","year":"2007","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib40","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Statins have a dose-dependent effect on amputation and survival in peripheral artery disease patients","volume":"3","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(16)30012-2","article-title":"Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality","volume":"4","author":"Jeffcoate","year":"2016","journal-title":"The Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2019.09.012_bib42","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"Suppl S","key":"10.1016\/j.atherosclerosis.2019.09.012_bib43","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J. Vasc. Surg."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019314996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:40:29Z","timestamp":1758156029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019314996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"alternative-id":["S0021915019314996"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.012","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}